MSB 2.58% 94.5¢ mesoblast limited

need for soine product: As for the spinal surgery trial, the...

  1. 871 Posts.
    lightbulb Created with Sketch. 92
    need for soine product:

    As for the spinal surgery trial, the company hopes to commence a phase three trial this year. Several surgeons participated in the phase two trial and discussed their preliminary observations with Becker's Spine Review:

    "We really need a therapy like this," says Hyun Bae, MD, medical director and director of spine education at Cedars-Sinai Spine Center, in a Becker's Spine Review report. "We don't currently know what to do with these patients; surgery sounds like a big hurdle to them, so we do other therapies to try to help. I think Mesoblast has great promise because we can take these patients and return them to regular activity without surgery."
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.